Philipp Ufer serves as the Head of Strategy and M&A at Medicover since November 2022, contributing to the strategic direction and mergers & acquisitions for Medicover Diagnostic Services, one of Europe's leading healthcare providers with over 40,000 employees. Ufer also holds the position of Head of Strategy at NIPD Genetics starting February 2023 and previously served on the Board of Ottobock from April 2021 to November 2022. With extensive experience in corporate strategy development, post-merger integration, and operational optimization from roles at Strategy& and various internships in finance and strategic development, Ufer has developed a strong background in the healthcare and pharmaceutical sectors, supported by advanced academic credentials in Business Administration and Finance from prestigious institutions such as INSEAD and The London School of Economics.